Poolbeg Pharma PLC (POLB)

London
7.90
+1.50(+25.00%)
  • Volume:
    11,841,624
  • Bid/Ask:
    0.00/0.00
  • Day's Range:
    6.56 - 7.90

POLB Overview

Prev. Close
6
Day's Range
6.56-7.9
Revenue
-
Open
6.25
52 wk Range
4.13-13.3
EPS
-
Volume
11,841,624
Market Cap
30M
Dividend (Yield)
N/A
(N/A)
Average Volume (3m)
896,302
P/E Ratio
-
Beta
-
1-Year Change
-
Shares Outstanding
500,000,000
Next Earnings Date
-
What is your sentiment on Poolbeg Pharma?
or
Market is currently closed. Voting is open during market hours.

Poolbeg Pharma PLC Company Profile

Poolbeg Pharma PLC Company Profile

Employees
0

Poolbeg Pharma PLC operates as a clinical stage infectious disease pharmaceutical company in the United Kingdom. Its products include POLB 001, a p38 MAP Kinase inhibitor for the treatment of severe influenza; POLB 002, an inlicensed firstinclass intranasally administered RNAbased immunotherapy for respiratory virus infections; and POLB 003, a late pre-clinical stage Melioidosis vaccine. The company also has licensed access to micro and nanoencapsulation technology to develop an oral vaccine delivery platform that delivers immune stimulating antigens to various areas of the gut; and artificial intelligence powered drug program. In addition, it is involved in the development of biomarker platform to identify those at risk of developing severe disease; and vaccine discovery platform, a model-derived discovery platform to identify new vaccine candidates. Poolbeg Pharma PLC was incorporated in 2021 and is headquartered in London, the United Kingdom.

Read More

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong BuyStrong BuyStrong BuyStrong BuyNeutral
Technical IndicatorsStrong BuyStrong BuyStrong BuyBuyBuy
SummaryStrong BuyStrong BuyStrong BuyStrong BuyNeutral
  • I got the extra dividends wrong -just waiting to see what they come up with-if anything-prior to the 18/19? April release date on rht POLB dividend share-
    0
    • This share has some interesting products in the pipeline .It is been devolved out of Open Orphan.Well worth researching both companies-Orph gave its shareholders an exceptional dividend in POLB and is ue to announce a further 2 if not 3 dividends including a cash one before year end.
      0
      • Looks a load of rubbish like open orphan but what do i know
        0